Company / Depreciation & Amortization
bioAffinity Technologies, Inc. Depreciation & Amortization History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$605.6K
FY2025
5-year range
$4.8K / $605.6K
FY2022-FY2025
Trend
+142.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $4,817 in FY2022 to $605,637 in FY2025.
Based on SEC 10-K filings.
$605,637 in FY2025 with a 3-year CAGR of +401.0%.
Increased from $10,182 to $605,637 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +401.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- bioAffinity Technologies, Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 3-year CAGR of +401.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 142.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $605.6K | +142.7% |
| FY2024 | $249.6K | +2351.3% |
| FY2023 | $10.2K | +111.4% |
| FY2022 | $4.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026